In the context of cancer, smart polymers can be designed to respond to specific conditions found in the tumor microenvironment. For example, the pH in tumor tissues is often lower (more acidic) compared to normal tissues. Smart polymers can be engineered to release their therapeutic payload in response to this acidic environment, ensuring that the drug is released directly at the tumor site, minimizing damage to healthy tissues.
